Bcl-2 overexpression confers cancer cell resistance pertaining to taxanes and, since KEMTUB10 does not prominently rely on Blc-2 phosphorylation to induce apoptosis, the compound is less susceptible to acquired Bcl-2 resistance [49]. This evidence concerns the gene BCL2 and cancer.